Oncology Corporate Profile
Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs. These macrocycles represent a new drug class complementary to the classical small molecules and large biopharmaceuticals.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|POL6326||CXCR4 receptor antagonist||Breast cancer||I|
|POL6326||CXCR4 receptor antagonist||Various cancer types||I|